The Center for Advanced Neurological Research, KSHEMA was awarded a patent in April 2024, for the development of a sensitive cell based assay for detection of myelin oligodendrocyte glycoprotein antibody (MOG IgG). This is the second patent awarded to the Center for its original research and contributions.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.